126 related articles for article (PubMed ID: 7197189)
21. [Clinical evaluation of cisplatin in children with malignant solid tumors. Pediatric Cisplatin Study Group].
Suganuma Y; Ise T; Akiyama Y; Bessho F; Fukazawa K; Hirotsu T; Kitamura T; Koide A; Matsuyama K; Muchi H
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3083-90. PubMed ID: 3674893
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
Vietti TJ; Nitschke R; Starling KA; van Eys J
Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
[TBL] [Abstract][Full Text] [Related]
23. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
De Bernardi B; Nicolas B; Boni L; Indolfi P; Carli M; Cordero Di Montezemolo L; Donfrancesco A; Pession A; Provenzi M; di Cataldo A; Rizzo A; Tonini GP; Dallorso S; Conte M; Gambini C; Garaventa A; Bonetti F; Zanazzo A; D'Angelo P; Bruzzi P;
J Clin Oncol; 2003 Apr; 21(8):1592-601. PubMed ID: 12697885
[TBL] [Abstract][Full Text] [Related]
24. Is more better? Dose intensity in neuroblastoma.
Anderson JR; Coccia PF
J Clin Oncol; 1991 Jun; 9(6):902-4. PubMed ID: 2033426
[No Abstract] [Full Text] [Related]
25. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
Kushner BH; O'Reilly RJ; LaQuaglia M; Cheung NK
Cancer; 1990 Sep; 66(6):1095-100. PubMed ID: 2400963
[TBL] [Abstract][Full Text] [Related]
26. Total-body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastoma.
Green AA; Hustu HO; Palmer R; Pinkel D
Cancer; 1976 Dec; 38(6):2250-7. PubMed ID: 1000465
[TBL] [Abstract][Full Text] [Related]
27. Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Splinter TA; Sahmoud T; Festen J; van Zandwijk N; Sörenson S; Clerico M; Burghouts J; Dautzenberg B; Kho GS; Kirkpatrick A; Giaccone G
J Clin Oncol; 1996 Jan; 14(1):127-34. PubMed ID: 8558187
[TBL] [Abstract][Full Text] [Related]
28. Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.
O'Connell MJ; Anderson J; Merrill JM; Bennett JM; Glick JH; Berard CW; Neiman RS; Brodovsky HS
Cancer Treat Rep; 1982 Dec; 66(12):2021-5. PubMed ID: 6814757
[TBL] [Abstract][Full Text] [Related]
29. [The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
Jankowski RP; Vahrson H
Med Klin; 1977 Dec; 72(49):2122-6. PubMed ID: 337083
[TBL] [Abstract][Full Text] [Related]
30. Cis-platinum (CDDP) plus etoposide (VP-16-213) and treatment of disseminated neuroblastoma.
Helson L
Anticancer Res; 1986; 6(6):1337-40. PubMed ID: 3813490
[TBL] [Abstract][Full Text] [Related]
31. [Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
Chatelut E; Canal P; De Forni M; Chevreau C; Houin G; Bugat R
Bull Cancer; 1989; 76(8):893-6. PubMed ID: 2620120
[No Abstract] [Full Text] [Related]
32. Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.
Hayes FA; Green AA; Senzer N; Pratt CB
Cancer Treat Rep; 1979 Apr; 63(4):547-8. PubMed ID: 445508
[No Abstract] [Full Text] [Related]
33. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
Ehrlich CE; Einhorn L; Williams SD; Morgan J
Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
[No Abstract] [Full Text] [Related]
35. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
37. Hypersensitivity reactions to teniposide (VM-26): an analysis.
O'Dwyer PJ; King SA; Fortner CL; Leyland-Jones B
J Clin Oncol; 1986 Aug; 4(8):1262-9. PubMed ID: 3525769
[TBL] [Abstract][Full Text] [Related]
38. Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study.
Nitschke R; Starling K; Lui VK; Pullen J
Cancer Treat Rep; 1981; 65(11-12):1105-8. PubMed ID: 7028253
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of advanced neuroblastoma by the protocol of the Welfare Ministry used by the Sawaguchi Group].
Shida S; Arioka H; Hatayama Y; Nakadate H; Hatae Y; Takeda T
Gan To Kagaku Ryoho; 1988 Mar; 15(3):425-9. PubMed ID: 3348628
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.
Rossi C; Zucchetti M; Sessa C; Urso R; Mangioni C; D'Incalci M
Cancer Chemother Pharmacol; 1984; 13(3):211-4. PubMed ID: 6488441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
